Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH)
Small-molecule inhibitors of HIF-PHD2: a valid strategy to renal anemia treatment in clinical therapy - MedChemComm (RSC Publishing)
Treatment of anemia in difficult-to-manage patients with chronic kidney disease - Kidney International Supplements
Anemia of chronic kidney disease: Will new agents deliver on their promise? | Cleveland Clinic Journal of Medicine
Ap romising novelt herapeutic approach for the treatment of anemia:... | Download Scientific Diagram
APExBIO - DMOG|Competitive HIF-PH inhibitor, cell-permeable|CAS# 89464-63-1
HIF-PHD inhibitors in renal anemia | Update on phase 3 clinical trials
Oxygen biology in the CKD patients
Daprodustat
Overview of hypoxia-inducible factor (HIF) regulation of... | Download Scientific Diagram
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
Frontiers | HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD - ScienceDirect
Daprodustat (GSK1278863) is An Orally Active HIF-PH Inhibitor
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD - ScienceDirect
![PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/954f37aaed4c29d5041d58192b31cdf86184379a/2-Figure1-1.png "PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar")
PDF] Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease. | Semantic Scholar
Chemical structures of HIF-PH inhibitors. | Download Scientific Diagram
Hif ph inhibitors for anemia in ckd | PPT
Hif ph inhibitors for anemia in ckd | PPT
Molecules | Free Full-Text | Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
Everything You Need to Know About HIF-PH Inhibitors
Biomedicines | Free Full-Text | HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
a, b HIF activity under normoxic/ hypoxic conditions and HIF-PHI... | Download Scientific Diagram
Biomedicines | Free Full-Text | HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
SEC Filing | FibroGen, Inc.
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond | Nature Reviews Nephrology
The roles of HIF-1α signaling in cardiovascular diseases - ScienceDirect
